Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
China
· Delayed Price · Currency is CNY 179.74
+0.96 (0.54%)
Mar 10, 2026, 12:34 PM CST
SHE:300760 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 216,215 | 308,395 | 351,450 | 382,132 | 461,774 | 517,884 | Upgrade
|
| Market Cap Growth | -29.63% | -12.25% | -8.03% | -17.25% | -10.83% | 134.19% | Upgrade
|
| Enterprise Value | 204,006 | 295,955 | 332,043 | 366,958 | 449,158 | 500,484 | Upgrade
|
| Last Close Price | 178.78 | 249.78 | 276.81 | 292.26 | 348.13 | 387.49 | Upgrade
|
| PE Ratio | 25.17 | 26.43 | 30.34 | 39.78 | 57.71 | 77.79 | Upgrade
|
| Forward PE | 25.35 | 22.32 | 26.68 | 34.86 | 48.63 | 68.16 | Upgrade
|
| PS Ratio | 6.54 | 8.40 | 10.06 | 12.58 | 18.27 | 24.63 | Upgrade
|
| PB Ratio | 4.89 | 7.57 | 10.54 | 11.94 | 17.12 | 22.24 | Upgrade
|
| P/TBV Ratio | 10.08 | 17.10 | 13.62 | 14.93 | 22.34 | 24.77 | Upgrade
|
| P/FCF Ratio | 32.94 | 29.45 | 41.97 | 37.37 | 60.79 | 67.37 | Upgrade
|
| P/OCF Ratio | 25.05 | 24.81 | 31.77 | 31.47 | 51.32 | 58.39 | Upgrade
|
| PEG Ratio | 4.48 | 1.73 | 1.28 | 1.46 | 2.51 | 2.66 | Upgrade
|
| EV/Sales Ratio | 6.17 | 8.06 | 9.51 | 12.09 | 17.77 | 23.80 | Upgrade
|
| EV/EBITDA Ratio | 18.56 | 21.62 | 25.24 | 32.80 | 47.88 | 64.74 | Upgrade
|
| EV/EBIT Ratio | 22.09 | 23.92 | 27.08 | 35.25 | 51.25 | 68.94 | Upgrade
|
| EV/FCF Ratio | 31.08 | 28.26 | 39.66 | 35.89 | 59.13 | 65.10 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | - | Upgrade
|
| Debt / FCF Ratio | 0.06 | 0.03 | 0.04 | 0.02 | 0.03 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.39 | -0.40 | -0.56 | -0.72 | -0.56 | -0.68 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.58 | -1.19 | -1.40 | -2.05 | -1.61 | -2.05 | Upgrade
|
| Net Debt / FCF Ratio | -2.61 | -1.56 | -2.21 | -2.24 | -1.99 | -2.06 | Upgrade
|
| Asset Turnover | 0.57 | 0.70 | 0.74 | 0.72 | 0.71 | 0.71 | Upgrade
|
| Inventory Turnover | 2.64 | 3.15 | 3.19 | 2.89 | 2.50 | 2.54 | Upgrade
|
| Quick Ratio | 1.99 | 1.93 | 2.21 | 2.21 | 2.00 | 2.15 | Upgrade
|
| Current Ratio | 2.55 | 2.46 | 2.66 | 2.60 | 2.47 | 2.63 | Upgrade
|
| Return on Equity (ROE) | 20.52% | 31.69% | 35.44% | 32.60% | 31.85% | 31.78% | Upgrade
|
| Return on Assets (ROA) | 9.88% | 14.79% | 16.19% | 15.33% | 15.34% | 15.39% | Upgrade
|
| Return on Invested Capital (ROIC) | 30.47% | 56.83% | 91.30% | 87.42% | 79.76% | 110.44% | Upgrade
|
| Return on Capital Employed (ROCE) | 19.10% | 26.80% | 32.40% | 29.80% | 29.70% | 29.00% | Upgrade
|
| Earnings Yield | 3.98% | 3.78% | 3.30% | 2.51% | 1.73% | 1.29% | Upgrade
|
| FCF Yield | 3.04% | 3.40% | 2.38% | 2.68% | 1.65% | 1.48% | Upgrade
|
| Dividend Yield | 2.24% | 2.51% | 2.10% | 1.54% | 1.00% | 0.65% | Upgrade
|
| Payout Ratio | 65.19% | 74.92% | 92.12% | 44.06% | 37.98% | 27.39% | Upgrade
|
| Buyback Yield / Dilution | 0.09% | 0.04% | -0.11% | 0.36% | 0.07% | 0.00% | Upgrade
|
| Total Shareholder Return | 2.33% | 2.55% | 1.98% | 1.90% | 1.08% | 0.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.